Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol.
Diabetes Ther
; 10(1): 329-331, 2019 02.
Article
en En
| MEDLINE
| ID: mdl-30523582
ABSTRACT
In the original publication, the text in Table 2 stated 'Hypersensitivity to the active substance, to Ferinject, or to any of its excipients'.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Diabetes Ther
Año:
2019
Tipo del documento:
Article
País de afiliación:
Alemania